Labcorp Holdings Inc. (LH)
Labcorp Holdings Inc. (LH) Quarterly Net Income
The quarterly net income for Labcorp Holdings Inc. (LH) is $277.80M with a period-over-period change of +68.67%. Quarterly net income is profit after expenses, taxes, interest, and other items for the latest fiscal quarter.
LH Quarterly Net Income Chart
Quarterly Net Income History
| Date | Quarterly Net Income | % Change |
|---|---|---|
| Q1 2026 | $277.80M | +68.67% |
| Q4 2025 | $164.70M | (36.92%) |
| Q3 2025 | $261.10M | +9.75% |
| Q2 2025 | $237.90M | +11.80% |
| Q1 2025 | $212.80M | +48.40% |
| Q4 2024 | $143.40M | (15.30%) |
| Q3 2024 | $169.30M | (17.54%) |
| Q2 2024 | $205.30M | (9.96%) |
| Q1 2024 | $228.00M | +236.45% |
| Q4 2023 | ($167.10M) | (191.16%) |
| Q3 2023 | $183.30M | (2.96%) |
| Q2 2023 | $188.90M | (11.27%) |
| Q1 2023 | $212.90M | +179.76% |
| Q4 2022 | $76.10M | (78.43%) |
| Q3 2022 | $352.80M | (1.62%) |
| Q2 2022 | $358.60M | (27.05%) |
| Q1 2022 | $491.60M | (11.10%) |
| Q4 2021 | $553.00M | (5.84%) |
| Q3 2021 | $587.30M | +25.65% |
| Q2 2021 | $467.40M | (39.27%) |
| Q1 2021 | $769.60M | (17.98%) |
| Q4 2020 | $938.30M | +33.39% |
| Q3 2020 | $703.40M | +203.71% |
| Q2 2020 | $231.60M | +173.01% |
| Q1 2020 | ($317.20M) | (239.67%) |
| Q4 2019 | $227.10M | +2.90% |
| Q3 2019 | $220.70M | +15.91% |
| Q2 2019 | $190.40M | +2.59% |
| Q1 2019 | $185.60M | +17.54% |
| Q4 2018 | $157.90M | (59.60%) |
| Q3 2018 | $390.80M | +67.15% |
| Q2 2018 | $233.80M | +34.99% |
| Q1 2018 | $173.20M | (75.50%) |
| Q4 2017 | $706.80M | +291.36% |
| Q3 2017 | $180.60M | (4.24%) |
| Q2 2017 | $188.60M | (1.87%) |
| Q1 2017 | $192.20M | +4.23% |
| Q4 2016 | $184.40M | +2.73% |
| Q3 2016 | $179.50M | (9.43%) |
| Q2 2016 | $198.20M | +23.72% |
| Q1 2016 | $160.20M | +40.28% |
| Q4 2015 | $114.20M | (25.26%) |
| Q3 2015 | $152.80M | (9.26%) |
| Q2 2015 | $168.40M | +23957.14% |
| Q1 2015 | $700,000 | (99.41%) |
| Q4 2014 | $119.60M | (12.83%) |
| Q3 2014 | $137.20M | (2.90%) |
| Q2 2014 | $141.30M | +24.93% |
| Q1 2014 | $113.10M | (10.45%) |
| Q4 2013 | $126.30M | (14.83%) |
| Q3 2013 | $148.30M | (2.37%) |
| Q2 2013 | $151.90M | +3.19% |
| Q1 2013 | $147.20M | +22.46% |
| Q4 2012 | $120.20M | (18.78%) |
| Q3 2012 | $148.00M | (3.46%) |
| Q2 2012 | $153.30M | (5.14%) |
| Q1 2012 | $161.60M | +19.35% |
| Q4 2011 | $135.40M | +0.82% |
| Q3 2011 | $134.30M | +9.28% |
| Q2 2011 | $122.90M | (3.30%) |
| Q1 2011 | $127.10M | (3.57%) |
| Q4 2010 | $131.80M | (5.86%) |
| Q3 2010 | $140.00M | (8.91%) |
| Q2 2010 | $153.70M | +15.83% |
| Q1 2010 | $132.70M | (7.01%) |
| Q4 2009 | $142.70M | +8.60% |
| Q3 2009 | $131.40M | (5.74%) |
| Q2 2009 | $139.40M | +4.97% |
| Q1 2009 | $132.80M | +12.45% |
| Q4 2008 | $118.10M | +5.54% |
| Q3 2008 | $111.90M | +7.39% |
| Q2 2008 | $104.20M | (20.03%) |
| Q1 2008 | $130.30M | +13.90% |
| Q4 2007 | $114.40M | +2.88% |
| Q3 2007 | $111.20M | (13.60%) |
| Q2 2007 | $128.70M | +5.06% |
| Q1 2007 | $122.50M | +18.13% |
| Q4 2006 | $103.70M | (5.38%) |
| Q3 2006 | $109.60M | (5.84%) |
| Q2 2006 | $116.40M | +14.23% |
| Q1 2006 | $101.90M | +14.62% |
| Q4 2005 | $88.90M | (6.12%) |
| Q3 2005 | $94.70M | (10.66%) |
| Q2 2005 | $106.00M | +9.73% |
| Q1 2005 | $96.60M | +13.92% |
| Q4 2004 | $84.80M | (8.42%) |
| Q3 2004 | $92.60M | (5.80%) |
| Q2 2004 | $98.30M | +12.60% |
| Q1 2004 | $87.30M | +12.50% |
| Q4 2003 | $77.60M | (6.62%) |
| Q3 2003 | $83.10M | (3.82%) |
| Q2 2003 | $86.40M | +16.91% |
| Q1 2003 | $73.90M | +39.43% |
| Q4 2002 | $53.00M | (7.50%) |
| Q3 2002 | $57.30M | (27.01%) |
| Q2 2002 | $78.50M | - |
About Labcorp Holdings Inc.
Labcorp Holdings, Inc. offers vital diagnostic laboratory services, enabling medical professionals, healthcare facilities, pharmaceutical firms, scientific investigators, and patients to make well-informed and confident choices. The company commenced operations on April 16, 2024, and its main office is situated in Burlington, NC.
- Sector
- Healthcare
- Industry
- Medical - Diagnostics & Research
- CEO
- Adam H. Schechter